Blurbs

Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Arvinas Holding Company (ARVN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Irhythm Technologies (IRTCResearch Report) and Arvinas Holding Company (ARVNResearch Report) with bullish sentiments.

Irhythm Technologies (IRTC)

Morgan Stanley analyst Cecilia Furlong maintained a Buy rating on Irhythm Technologies today and set a price target of $172.00. The company’s shares closed last Thursday at $127.80.

According to TipRanks.com, Furlong is a 4-star analyst with an average return of 17.4% and a 46.5% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Edwards Lifesciences.

Irhythm Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $171.50, representing a 29.5% upside. In a report issued on September 12, J.P. Morgan also maintained a Buy rating on the stock with a $185.00 price target.

See today’s best-performing stocks on TipRanks >>

Arvinas Holding Company (ARVN)

BMO Capital analyst Etzer Darout maintained a Buy rating on Arvinas Holding Company today and set a price target of $95.00. The company’s shares closed last Thursday at $42.65, close to its 52-week low of $34.90.

According to TipRanks.com, Darout is a 5-star analyst with an average return of 26.2% and a 40.9% success rate. Darout covers the Healthcare sector, focusing on stocks such as Y-Mabs Therapeutics, CytomX Therapeutics, and Fate Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Arvinas Holding Company with a $87.82 average price target, a 100.6% upside from current levels. In a report issued on September 9, Barclays also initiated coverage with a Buy rating on the stock with a $90.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on IRTC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos